Raloxifene would not act like estrogen inside the uterus and is not linked to an increased possibility of uterine cancer.Importantly, we reveal that targeted degradation of Wager proteins using proteolysis-focusing on chimera (PROTAC) technology triggers mobile Loss of life in cultured prostate cancer cells and brings about tumor growth inhibition